16154

    0

    REMUS

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    REMUS PHARMACEUTICALS L Share Price Today

    REMUS PHARMACEUTICALS L is currently trading at ₹772, up by ₹8.45 from the previous close. The stock touched an intraday high of ₹785.00 and a low of ₹750.00 during the latest trading session. Over the past one year, REMUS PHARMACEUTICALS L has delivered a loss of 22.49%, while the stock has gained 9.68% in the last one month.

    REMUS PHARMACEUTICALS L performance

    Today’s low Today’s high
    ₹ 750.00 ₹ 785.00
    ₹ 779.25
    52 week low 52 week high
    ₹ 580.00 ₹ 1021.80
    ₹ 779.25
    Open Price ₹ 755.00
    Prev. Close ₹ 763.55
    Volume (Shares) 3100.00
    Total traded value ₹ 24.15
    Upper Circuit ₹ 916.25
    Lower Circuit ₹ 610.85
    info

    Investment Returns

    Over 1 Month 9.68% Over 3 Months 21.60% Over 6 Months 6.04% Over 1 Year -22.49%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    REMUS PHARMACEUTICALS L fundamentals


    • Market cap (Cr) 918.30
    • P/E Ratio (TTM) 36.41
    • Beta 0.86
    • Book Value / share 276.40
    • Return on equity 10.06%
    • EPS (TTM) 20.97
    • Dividend yield 0.07%
    • Net profit/quarter (Cr) 0.00
    info icon alternate text
    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield 0.07%
    • Net profit/quarter (Cr) [-]
    info icon alternate text

    REMUS PHARMACEUTICALS L Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 93.99
    Operating Expense 67.60
    Net Profit 24.71
    Net Profit Margin (%) 26.29
    Earnings Per Share (EPS) 20.96
    EBITDA 36.55
    Effective Tax Rate (%) 25.63
    Particulars MAR 2025 (Values in Cr)
    Revenue 79.16
    Operating Expense 55.43
    Net Profit 19.90
    Net Profit Margin (%) 25.13
    Earnings Per Share (EPS) 33.75
    EBITDA 28.89
    Effective Tax Rate (%) 25.30
    Particulars MAR 2024 (Values in Cr)
    Revenue 63.94
    Operating Expense 44.40
    Net Profit 16.62
    Net Profit Margin (%) 25.99
    Earnings Per Share (EPS) 29.40
    EBITDA 23.81
    Effective Tax Rate (%) 25.63
    Particulars MAR 2023 (Values in Cr)
    Revenue 45.03
    Operating Expense 35.19
    Net Profit 8.50
    Net Profit Margin (%) 18.87
    Earnings Per Share (EPS) 83.24
    EBITDA 12.12
    Effective Tax Rate (%) 25.50
    Particulars MAR 2022 (Values in Cr)
    Revenue 24.72
    Operating Expense 20.83
    Net Profit 3.43
    Net Profit Margin (%) 13.87
    Earnings Per Share (EPS) 34.34
    EBITDA 4.85
    Effective Tax Rate (%) 25.59
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 434.40
    ROE % 18.58
    ROCE % 21.60
    Total Debt to Total Equity 0.09
    EBITDA Margin 8.17
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 1072.72
    ROE % 15.40
    ROCE % 17.79
    Total Debt to Total Equity 0.09
    EBITDA Margin 14.93
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 411.24
    ROE % 10.06
    ROCE % 13.33
    Total Debt to Total Equity 0.02
    EBITDA Margin 36.50
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 1044.56
    ROE % 19.25
    ROCE % 24.46
    Total Debt to Total Equity 0.07
    EBITDA Margin 37.24
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 176.36
    ROE % 66.10
    ROCE % 68.21
    Total Debt to Total Equity 0.32
    EBITDA Margin 26.92
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 65.78
    ROE % 70.58
    ROCE % 92.25
    Total Debt to Total Equity 0.05
    EBITDA Margin 19.66
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 3143.70
    ROE % 41.09
    ROCE % 48.98
    Total Debt to Total Equity 0.12
    EBITDA Margin 8.74
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 8.14
    Total Assets 432.64
    Total Liabilities 432.64
    Total Equity 282.55
    Share Outstanding 0
    Price to Book Ratio 5.44
    Return on Assets (%) 6.71
    Return on Capital (%) 9.58
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 13.85
    Total Assets 333.11
    Total Liabilities 333.11
    Total Equity 175.21
    Share Outstanding 0
    Price to Book Ratio 6.61
    Return on Assets (%) 6.16
    Return on Capital (%) 10.99
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 4.37
    Total Assets 280.31
    Total Liabilities 280.31
    Total Equity 242.22
    Share Outstanding 0
    Price to Book Ratio 5.44
    Return on Assets (%) 7.09
    Return on Capital (%) 8.14
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 10.84
    Total Assets 183.49
    Total Liabilities 183.49
    Total Equity 153.55
    Share Outstanding 0
    Price to Book Ratio 6.61
    Return on Assets (%) 9.05
    Return on Capital (%) 10.72
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 3.03
    Total Assets 34.66
    Total Liabilities 34.66
    Total Equity 19.13
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 24.53
    Return on Capital (%) 31.4
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.14
    Total Assets 15.86
    Total Liabilities 15.86
    Total Equity 6.57
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 21.65
    Return on Capital (%) 50.73
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.83
    Total Assets 11.01
    Total Liabilities 11.01
    Total Equity 3.14
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 9.61
    Return on Capital (%) 30.96
    Particulars MAR 2025 (Values in Cr)
    Net Income 47.34
    Cash from Operations 14.46
    Cash from Investing -10.55
    Cash from Financing 6.07
    Net change in Cash 2.51
    Free Cash Flow 18.44
    Particulars MAR 2024 (Values in Cr)
    Net Income 30.17
    Cash from Operations 7.16
    Cash from Investing -30.11
    Cash from Financing 27.67
    Net change in Cash -1.09
    Free Cash Flow 10.45
    Particulars MAR 2025 (Values in Cr)
    Net Income 26.64
    Cash from Operations 23.11
    Cash from Investing -12.42
    Cash from Financing -1.42
    Net change in Cash 1.75
    Free Cash Flow 27.06
    Particulars MAR 2024 (Values in Cr)
    Net Income 22.35
    Cash from Operations 12.56
    Cash from Investing -47.24
    Cash from Financing 41.63
    Net change in Cash 0.70
    Free Cash Flow 16.15
    Particulars MAR 2023 (Values in Cr)
    Net Income 11.41
    Cash from Operations 8.31
    Cash from Investing -15.19
    Cash from Financing 11.76
    Net change in Cash 1.88
    Free Cash Flow 11.04
    Particulars MAR 2022 (Values in Cr)
    Net Income 4.61
    Cash from Operations 6.23
    Cash from Investing -4.54
    Cash from Financing -0.17
    Net change in Cash 0.31
    Free Cash Flow 6.30
    Particulars MAR 2021 (Values in Cr)
    Net Income 1.40
    Cash from Operations 0.24
    Cash from Investing -0.13
    Cash from Financing -0.11
    Net change in Cash -0.36
    Free Cash Flow 0.31
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.08 12.84 1.50 238.18 23.12 38.85
    BLISS GVS PHARMA LTD 530.35 43.05 4.71 5624.69 118.35 541.75
    CIPLA LTD 1453.50 30.85 3.41 117420.32 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 356.70 15.73 2.58 1049.80 256.40 399.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.08 21.73 4.00 238.18 23.12 38.85
    AMRUTAJAN HEALTH LTD 539.05 24.16 4.20 1558.43 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8054.15 105.19 23.07 20135.38 7630.00 9850.00
    BLISS GVS PHARMA LTD 530.35 57.21 4.86 5624.69 118.35 541.75

    REMUS PHARMACEUTICALS L shareholding pattern

    Holding
    22.93%
    70.95%
    5.28%
    0.82%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    REMUS PHARMACEUTICALS L Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    779.25 2.05 redarrow
    red-green-graph indicator
    3 Bearish
    13 Bullish
    • 5 Days 783.00
    • 26 Days 756.00
    • 10 Days 776.30
    • 50 Days 736.00
    • 12 Days 772.90
    • 100 Days 721.40
    • 20 Days 762.20
    • 200 Days 753.20
    769.85 PIVOT
    First Support 753.70 First Resistance 779.70 Second Support 743.85 Second Resistance 795.85 Third Support 727.70 Third Resistance 805.70
    RSI 51.57 ADX 29.94 MACD 16.85 Williams % R -43.63 Commodity Channel Index (CCI) 44.19
    Date 2026-06-29 Week 7840.00 Same Day 3500.00 Month 4533.00
    1 Year 0.86 3 Year 1.00
    Over 1 Month
    9.68% down
    Over 1 Year
    -22.49% down
    Over 3 Months
    21.60% down
    Over 3 Years
    18.31% down
    Over 6 Months
    6.04% down
    Over 5 Years
    0.00% down

    REMUS PHARMACEUTICALS L Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    14 Nov 2025 0.5 Interim 1 14 Nov 2025 Equity shares
    18 Sep 2025 0.5 Final 18 Sep 2025 Equity shares
    19 Nov 2024 1.0 Interim 20 Nov 2024 Equity shares
    02 May 2024 4.0 Interim 2 02 May 2024 Equity shares
    27 Oct 2023 2.0 Interim 28 Oct 2023 Equity shares
    15 Sep 2023 2.0 Final 15 Sep 2023 Equity shares
    Ex-Date Ex-Bonus Ratio
    04 Jul 2025 04 Jul 2025 1:1
    06 Jun 2024 06 Jun 2024 3:1

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Remus Pharmaceuticals Ltd?

    Answer Field

    Remus Pharmaceuticals Ltd share price is for NSE ₹ 772.00 & for BSE ₹ 0.00 as on Jun 30 2026 03:29 PM.

    What is the Market Cap of Remus Pharmaceuticals Ltd Share?

    Answer Field

    The market cap of Remus Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 30 2026 03:29 PM.

    What is the 52 Week High and Low of Remus Pharmaceuticals Ltd?

    Answer Field

    The 52 Week High and Low of Remus Pharmaceuticals Ltd for NSE is ₹ 1,021.80 and ₹ 580.00 and for BSE is ₹ 0.00 and ₹ 0.00.

    What is 1 year return for Remus Pharmaceuticals Ltd?

    Answer Field

    The 1 year returns on the stock has been -22.49%.

    What is the P/E Ratio of Remus Pharmaceuticals Ltd Share?

    Answer Field

    As on Jun 30 2026 03:29 PM the price-to-earnings (PE) ratio for Remus Pharmaceuticals Ltd share is 36.41.

    What is the PB ratio of Remus Pharmaceuticals Ltd Share?

    Answer Field

    As on Jun 30 2026 03:29 PM, the price-to-book (PB) ratio for Remus Pharmaceuticals Ltd share is 276.40.

    How to Buy Remus Pharmaceuticals Ltd Share?

    Answer Field

    You can trade in Remus Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Remus Pharmaceuticals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Remus Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Remus Pharmaceuticals Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |